Friday, September 22, 2023
25 C
Brunei Town
- Advertisement -

Trial begins on Omicron-specific vaccine booster

WASHINGTON (AFP) – United States (US) biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.  More details in Friday’s Borneo Bulletin.

- Advertisement -
spot_img

Latest article

spot_img